Please provide your email address to receive an email when new articles are posted on . Ametek, a multinational company involved in various industries, has acquired LKC. LKC makes RETeval, a handheld ...
RETeval™ is a handheld DR screening device that enables virtually any health care provider to screen for sight-threatening DR in less than three minutes per patient with no dilation regardless of ...
Point-of-care diagnostics company Welch Allyn and visual electrophysiology player LKC Technologies have signed an exclusive partnership for the former to distribute the latter's RETeval DR device, ...
GAITHERSBURG, Md., Dec. 4, 2014 /PRNewswire/ -- Welch Allyn, a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, and LKC Technologies, Inc., the ...
Please provide your email address to receive an email when new articles are posted on . VANCOUVER, British Columbia — A portable device may eliminate the need for sedated electroretinograms in ...
GAITHERSBURG, Md., April 28, 2014 /PRNewswire/ -- A rigorous multi-center clinical trial has completed testing over 400 diabetic patients to evaluate the effectiveness of RETeval(R) based visual ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
GAITHERSBURG, Md., Jan. 11, 2017 /PRNewswire/ -- LKC Technologies once again leads through innovation as the RET eval™ device, LKC's full function flash ERG/VEP system, was granted a patent (USPTO # 9 ...
GAITHERSBURG, Maryland, Sept. 4, 2014 /PRNewswire/ -- The EURETINA/ESCRS joint congress scheduled for 12-16 September is the setting for April Maa, MD, Primary Investigator, to present results from a ...
DW Healthcare Partners (DWHP) has announced it has completed an investment in LKC Technologies. LKC, based in Gaithersburg, Md., is a manufacturer of electrophysiology testing devices. Founded in 1975 ...
Early adopters have hailed the RETeval Complete as being useful for ophthalmologists treatinf children with uncertain visual potential. 1. RETeval Complete is one of the first non-mydriatic, ...
GAITHERSBURG, Md., April 28, 2014 /PRNewswire/ --A rigorous multi-center clinical trial has completed testing over 400 diabetic patients to evaluate the effectiveness of RETeval® based visual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results